Cartalax 20mg

Cartalax

• Form: Lyophilized powder
• Purity: >99%

Overview

Cartalax, also known as AED or T-31 peptide, is a synthetic peptide derived from the amino acid sequence of the alpha-1 chain of type XI collagen (Alanine–Glutamate–Aspartate). It has also been isolated from kidney extracts containing polypeptides. Classified among the Khavinson peptides, Cartalax has been investigated for its potential as a bioregulator, with research focusing on inflammation, cartilage repair, and possible roles in cellular aging.

Research Background

Peptides like Cartalax are studied for their potential influence on biological processes connected to osteoarthritis, fibroblast longevity, and tissue regeneration. Experimental findings suggest Cartalax may play a role in supporting fibroblast proliferation, reducing apoptosis, and modulating markers associated with aging and regeneration.

Mechanism of Interest

• Cell proliferation: Suggested to enhance expression of Ki-67, a marker of cellular division, potentially extending fibroblast lifespan.
• Cell regeneration: May increase CD98hc expression, a protein linked to cell vitality and repair processes.
• Anti-apoptotic action: Research indicates possible suppression of caspase-3 activity, which could reduce programmed cell death.
• Cartilage and tissue repair: Investigated for potential modulatory effects relevant to osteoarthritis and connective tissue health.

Molecular Information

• Molecular Formula: C12H19N3O8
• Molecular Weight: 333.29 g/mol
• Sequence: Ala–Glu–Asp
• Other Names: AED, T-31, SCHEMBL5324601